Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Redpoint Bio has received US patent for the use of assay technology used for the purpose of identifying potential activators of the TRPM5 ion channel.
Subscribe to our email newsletter
This patent is part of Redpoint Bio’s founding intellectual property portfolio, originally developed in the laboratory of Robert Margolskee, and exclusively licensed from the Mount Sinai School of Medicine.
The TRPM5 ion channel is highly expressed in taste receptor cells and is associated with the perception of bitter, sweet and savory tastes.
Raymond Salemme, CEO of Redpoint Bio, said: “We are very pleased to have received notice of this latest patent issuance, which we believe, in combination with a similar issuance announced in March 2008, further solidifies the company’s intellectual property position around technology for the discovery of taste modulators of the TRPM5 ion channel.”